Illumina, Icahn prepare for proxy showdown
BioPharma
Stay updated with breaking news from Robert Epstein. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Institutional Shareholder Services and Glass Lewis make recommendations ahead of proxy vote at Illumina's annual meeting on Thursday.
Illumina's director nominees bring deep commercial, scientific and business experience from leading organizations including Microsoft, Symantec, and Medco-UBC...
/PRNewswire/ -- Illumina (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that Institutional Shareholder...
Illumina is led by its world-class Board members and has best-in-class governance practicesCarl Icahn's recently released plan demonstrates his lack of understanding of both Illumina and the... | May 8, 2023